| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.006 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.078 | 0.008 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |